nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—NTRK1—periodontitis	0.766	1	CbGaD
Regorafenib—NTRK1—trigeminal ganglion—periodontitis	0.00464	0.0504	CbGeAlD
Regorafenib—FLT4—endothelium—periodontitis	0.00369	0.0401	CbGeAlD
Regorafenib—TEK—endothelium—periodontitis	0.00297	0.0322	CbGeAlD
Regorafenib—FLT1—endothelium—periodontitis	0.00287	0.0312	CbGeAlD
Regorafenib—DDR2—connective tissue—periodontitis	0.00286	0.0311	CbGeAlD
Regorafenib—KDR—endothelium—periodontitis	0.00242	0.0263	CbGeAlD
Regorafenib—FGFR2—mouth—periodontitis	0.00239	0.0259	CbGeAlD
Regorafenib—EPHX2—parotid gland—periodontitis	0.0022	0.0239	CbGeAlD
Regorafenib—KIT—endothelium—periodontitis	0.00215	0.0233	CbGeAlD
Regorafenib—RET—neck—periodontitis	0.00215	0.0233	CbGeAlD
Regorafenib—FGFR1—trigeminal ganglion—periodontitis	0.00207	0.0225	CbGeAlD
Regorafenib—FGFR2—neck—periodontitis	0.00204	0.0222	CbGeAlD
Regorafenib—FLT1—neck—periodontitis	0.00189	0.0206	CbGeAlD
Regorafenib—RAF1—neck—periodontitis	0.00188	0.0204	CbGeAlD
Regorafenib—RET—trigeminal ganglion—periodontitis	0.00185	0.0202	CbGeAlD
Regorafenib—EPHA2—trigeminal ganglion—periodontitis	0.00173	0.0188	CbGeAlD
Regorafenib—TEK—trigeminal ganglion—periodontitis	0.00169	0.0184	CbGeAlD
Regorafenib—KIT—mouth—periodontitis	0.00166	0.018	CbGeAlD
Regorafenib—FLT4—epithelium—periodontitis	0.00166	0.018	CbGeAlD
Regorafenib—FLT1—trigeminal ganglion—periodontitis	0.00163	0.0177	CbGeAlD
Regorafenib—EPHA2—parotid gland—periodontitis	0.00163	0.0177	CbGeAlD
Regorafenib—RAF1—trigeminal ganglion—periodontitis	0.00162	0.0176	CbGeAlD
Regorafenib—KDR—neck—periodontitis	0.0016	0.0174	CbGeAlD
Regorafenib—FLT1—parotid gland—periodontitis	0.00154	0.0167	CbGeAlD
Regorafenib—RET—connective tissue—periodontitis	0.00154	0.0167	CbGeAlD
Regorafenib—RAF1—parotid gland—periodontitis	0.00153	0.0166	CbGeAlD
Regorafenib—FGFR2—connective tissue—periodontitis	0.00146	0.0159	CbGeAlD
Regorafenib—RET—epithelium—periodontitis	0.00146	0.0159	CbGeAlD
Regorafenib—KIT—neck—periodontitis	0.00142	0.0154	CbGeAlD
Regorafenib—TEK—connective tissue—periodontitis	0.0014	0.0152	CbGeAlD
Regorafenib—FGFR2—epithelium—periodontitis	0.00139	0.0151	CbGeAlD
Regorafenib—PDGFRB—neck—periodontitis	0.00138	0.015	CbGeAlD
Regorafenib—KDR—trigeminal ganglion—periodontitis	0.00138	0.015	CbGeAlD
Regorafenib—EPHA2—epithelium—periodontitis	0.00136	0.0148	CbGeAlD
Regorafenib—FLT1—connective tissue—periodontitis	0.00136	0.0147	CbGeAlD
Regorafenib—RAF1—connective tissue—periodontitis	0.00135	0.0146	CbGeAlD
Regorafenib—TEK—epithelium—periodontitis	0.00133	0.0145	CbGeAlD
Regorafenib—KDR—parotid gland—periodontitis	0.0013	0.0142	CbGeAlD
Regorafenib—FLT1—epithelium—periodontitis	0.00129	0.014	CbGeAlD
Regorafenib—RAF1—epithelium—periodontitis	0.00128	0.0139	CbGeAlD
Regorafenib—PDGFRA—connective tissue—periodontitis	0.00127	0.0138	CbGeAlD
Regorafenib—KIT—trigeminal ganglion—periodontitis	0.00122	0.0133	CbGeAlD
Regorafenib—PDGFRB—trigeminal ganglion—periodontitis	0.0012	0.013	CbGeAlD
Regorafenib—KIT—parotid gland—periodontitis	0.00115	0.0125	CbGeAlD
Regorafenib—KDR—connective tissue—periodontitis	0.00115	0.0125	CbGeAlD
Regorafenib—PDGFRB—parotid gland—periodontitis	0.00113	0.0122	CbGeAlD
Regorafenib—KDR—epithelium—periodontitis	0.00109	0.0118	CbGeAlD
Regorafenib—ABL1—trigeminal ganglion—periodontitis	0.00107	0.0116	CbGeAlD
Regorafenib—KIT—connective tissue—periodontitis	0.00102	0.011	CbGeAlD
Regorafenib—ABL1—parotid gland—periodontitis	0.001	0.0109	CbGeAlD
Regorafenib—PDGFRB—connective tissue—periodontitis	0.000992	0.0108	CbGeAlD
Regorafenib—KIT—epithelium—periodontitis	0.000964	0.0105	CbGeAlD
Regorafenib—PDGFRB—epithelium—periodontitis	0.000942	0.0102	CbGeAlD
Regorafenib—ABL1—connective tissue—periodontitis	0.000884	0.00961	CbGeAlD
Regorafenib—ABCG2—trigeminal ganglion—periodontitis	0.000672	0.0073	CbGeAlD
Regorafenib—ABCG2—parotid gland—periodontitis	0.000634	0.00688	CbGeAlD
Regorafenib—ABCB1—trigeminal ganglion—periodontitis	0.000331	0.0036	CbGeAlD
Regorafenib—ABCB1—epithelium—periodontitis	0.000261	0.00284	CbGeAlD
Regorafenib—MAPK11—Developmental Biology—TNF—periodontitis	1.92e-05	0.000135	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NTRK1—periodontitis	1.92e-05	0.000135	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ACP5—periodontitis	1.91e-05	0.000135	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—FGF2—periodontitis	1.91e-05	0.000134	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NTRK1—periodontitis	1.9e-05	0.000134	CbGpPWpGaD
Regorafenib—KIT—Immune System—TLR4—periodontitis	1.89e-05	0.000133	CbGpPWpGaD
Regorafenib—ABL1—Immune System—AGER—periodontitis	1.88e-05	0.000132	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—MMP9—periodontitis	1.87e-05	0.000132	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CRP—periodontitis	1.87e-05	0.000132	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CRP—periodontitis	1.86e-05	0.000131	CbGpPWpGaD
Regorafenib—FGFR1—Axon guidance—IL6—periodontitis	1.86e-05	0.000131	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—IL6—periodontitis	1.84e-05	0.00013	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—FGF2—periodontitis	1.83e-05	0.000129	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—FGF2—periodontitis	1.83e-05	0.000129	CbGpPWpGaD
Regorafenib—BRAF—Disease—NOS2—periodontitis	1.82e-05	0.000128	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCR2—periodontitis	1.81e-05	0.000128	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—periodontitis	1.81e-05	0.000127	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—ADRB1—periodontitis	1.8e-05	0.000127	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—IL6—periodontitis	1.8e-05	0.000127	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—TLR4—periodontitis	1.79e-05	0.000126	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	1.79e-05	0.000126	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL1A—periodontitis	1.79e-05	0.000126	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—TLR4—periodontitis	1.79e-05	0.000126	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL18—periodontitis	1.79e-05	0.000126	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP3—periodontitis	1.78e-05	0.000126	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP3—periodontitis	1.77e-05	0.000125	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NTRK1—periodontitis	1.76e-05	0.000124	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TGFB1—periodontitis	1.76e-05	0.000124	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NTRK1—periodontitis	1.73e-05	0.000122	CbGpPWpGaD
Regorafenib—RAF1—Immune System—AGER—periodontitis	1.71e-05	0.000121	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—GGT1—periodontitis	1.71e-05	0.000121	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—GGT1—periodontitis	1.71e-05	0.000121	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—MMP9—periodontitis	1.71e-05	0.00012	CbGpPWpGaD
Regorafenib—FGFR2—Disease—NOS2—periodontitis	1.69e-05	0.000119	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CRP—periodontitis	1.68e-05	0.000118	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—IL6—periodontitis	1.67e-05	0.000118	CbGpPWpGaD
Regorafenib—KIT—Disease—NOS2—periodontitis	1.66e-05	0.000117	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	1.65e-05	0.000116	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—IL6—periodontitis	1.64e-05	0.000116	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TNF—periodontitis	1.64e-05	0.000116	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NTRK1—periodontitis	1.64e-05	0.000116	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP3—periodontitis	1.64e-05	0.000115	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NTRK1—periodontitis	1.64e-05	0.000115	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CRP—periodontitis	1.63e-05	0.000115	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—IL6—periodontitis	1.63e-05	0.000115	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—FGF2—periodontitis	1.62e-05	0.000114	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ACP5—periodontitis	1.62e-05	0.000114	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCR2—periodontitis	1.61e-05	0.000114	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP3—periodontitis	1.61e-05	0.000113	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—TLR4—periodontitis	1.61e-05	0.000113	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—ADRB1—periodontitis	1.61e-05	0.000113	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CXCL8—periodontitis	1.6e-05	0.000113	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—TGFB1—periodontitis	1.6e-05	0.000113	CbGpPWpGaD
Regorafenib—FGFR1—Disease—NOS2—periodontitis	1.57e-05	0.000111	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—NOS2—periodontitis	1.57e-05	0.00011	CbGpPWpGaD
Regorafenib—ABL1—Immune System—TLR4—periodontitis	1.57e-05	0.00011	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—IL6—periodontitis	1.55e-05	0.000109	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TGFB1—periodontitis	1.54e-05	0.000109	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP3—periodontitis	1.53e-05	0.000108	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IFNG—periodontitis	1.53e-05	0.000108	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP3—periodontitis	1.52e-05	0.000107	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—TGFB1—periodontitis	1.51e-05	0.000107	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CRP—periodontitis	1.5e-05	0.000105	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—FGF2—periodontitis	1.49e-05	0.000105	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—IL6—periodontitis	1.49e-05	0.000105	CbGpPWpGaD
Regorafenib—BRAF—Disease—FGF2—periodontitis	1.48e-05	0.000105	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC52A3—periodontitis	1.48e-05	0.000104	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NTRK1—periodontitis	1.48e-05	0.000104	CbGpPWpGaD
Regorafenib—KIT—Immune System—FGF2—periodontitis	1.46e-05	0.000103	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—GGT1—periodontitis	1.45e-05	0.000102	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—MMP9—periodontitis	1.45e-05	0.000102	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.45e-05	0.000102	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ACP5—periodontitis	1.45e-05	0.000102	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TNF—periodontitis	1.44e-05	0.000101	CbGpPWpGaD
Regorafenib—RAF1—Immune System—TLR4—periodontitis	1.43e-05	0.000101	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CCL2—periodontitis	1.43e-05	0.000101	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	1.42e-05	0.0001	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NOS2—periodontitis	1.41e-05	9.95e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ACP5—periodontitis	1.41e-05	9.95e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TGFB1—periodontitis	1.41e-05	9.93e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IFNG—periodontitis	1.4e-05	9.87e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—FGF2—periodontitis	1.39e-05	9.78e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—FGF2—periodontitis	1.38e-05	9.75e-05	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—TGFB1—periodontitis	1.38e-05	9.74e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IFNG—periodontitis	1.38e-05	9.7e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—FGF2—periodontitis	1.37e-05	9.69e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP3—periodontitis	1.37e-05	9.67e-05	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—IL6—periodontitis	1.37e-05	9.64e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL1B—periodontitis	1.36e-05	9.59e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—FGF2—periodontitis	1.35e-05	9.51e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CCL2—periodontitis	1.35e-05	9.51e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CCL2—periodontitis	1.35e-05	9.49e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—PTGS2—periodontitis	1.34e-05	9.43e-05	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	1.33e-05	9.35e-05	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—IL6—periodontitis	1.33e-05	9.34e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ACP5—periodontitis	1.32e-05	9.3e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TNF—periodontitis	1.32e-05	9.27e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NTRK1—periodontitis	1.32e-05	9.27e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IFNG—periodontitis	1.31e-05	9.2e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IFNG—periodontitis	1.3e-05	9.18e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.29e-05	9.12e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—FGF2—periodontitis	1.29e-05	9.09e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—FGF2—periodontitis	1.28e-05	9.03e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—FGF2—periodontitis	1.28e-05	9.01e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—NOS2—periodontitis	1.26e-05	8.87e-05	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—IL6—periodontitis	1.26e-05	8.85e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL1B—periodontitis	1.25e-05	8.81e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—FGF2—periodontitis	1.25e-05	8.79e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PTGS2—periodontitis	1.24e-05	8.74e-05	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—IL6—periodontitis	1.23e-05	8.69e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL1B—periodontitis	1.23e-05	8.65e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PPARA—periodontitis	1.23e-05	8.64e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PPARA—periodontitis	1.23e-05	8.64e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP3—periodontitis	1.22e-05	8.62e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—FGF2—periodontitis	1.22e-05	8.59e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—PTGS2—periodontitis	1.22e-05	8.58e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—FGF2—periodontitis	1.22e-05	8.56e-05	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—IL6—periodontitis	1.21e-05	8.51e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	1.2e-05	8.46e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—TGFB1—periodontitis	1.2e-05	8.42e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	1.18e-05	8.31e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IFNG—periodontitis	1.17e-05	8.27e-05	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—IL6—periodontitis	1.17e-05	8.25e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—IL6—periodontitis	1.17e-05	8.23e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL1B—periodontitis	1.16e-05	8.21e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL1B—periodontitis	1.16e-05	8.19e-05	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—IL6—periodontitis	1.16e-05	8.18e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CCL2—periodontitis	1.16e-05	8.18e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PTGS2—periodontitis	1.16e-05	8.14e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PTGS2—periodontitis	1.15e-05	8.12e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—FGF2—periodontitis	1.15e-05	8.11e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CCL2—periodontitis	1.15e-05	8.1e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IFNG—periodontitis	1.14e-05	8.06e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CXCL8—periodontitis	1.13e-05	7.95e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—FGF2—periodontitis	1.11e-05	7.83e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CXCL8—periodontitis	1.07e-05	7.52e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCL2—periodontitis	1.07e-05	7.51e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GGT1—periodontitis	1.07e-05	7.51e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CXCL8—periodontitis	1.06e-05	7.5e-05	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—IL6—periodontitis	1.06e-05	7.48e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—IL6—periodontitis	1.05e-05	7.41e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—FGF2—periodontitis	1.05e-05	7.39e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL1B—periodontitis	1.05e-05	7.38e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCL2—periodontitis	1.05e-05	7.37e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IFNG—periodontitis	1.05e-05	7.37e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PPARA—periodontitis	1.04e-05	7.33e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—FGF2—periodontitis	1.04e-05	7.32e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTGS2—periodontitis	1.04e-05	7.32e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—FGF2—periodontitis	1.03e-05	7.23e-05	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—IL6—periodontitis	1.03e-05	7.23e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MMP9—periodontitis	1.02e-05	7.2e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL1B—periodontitis	1.02e-05	7.19e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCL2—periodontitis	9.93e-06	7e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCL2—periodontitis	9.9e-06	6.98e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—TGFB1—periodontitis	9.67e-06	6.82e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MMP9—periodontitis	9.65e-06	6.8e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—FGF2—periodontitis	9.63e-06	6.78e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—FGF2—periodontitis	9.45e-06	6.66e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	9.42e-06	6.64e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—IL6—periodontitis	9.38e-06	6.61e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL1B—periodontitis	9.33e-06	6.57e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTGS2—periodontitis	9.26e-06	6.52e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CXCL8—periodontitis	9.17e-06	6.46e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CXCL8—periodontitis	9.09e-06	6.4e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GGT1—periodontitis	9.02e-06	6.35e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL6—periodontitis	9.01e-06	6.35e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—FGF2—periodontitis	8.97e-06	6.32e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—TGFB1—periodontitis	8.97e-06	6.32e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—FGF2—periodontitis	8.95e-06	6.31e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCL2—periodontitis	8.92e-06	6.29e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—TGFB1—periodontitis	8.81e-06	6.2e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ACP5—periodontitis	8.7e-06	6.13e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CXCL8—periodontitis	8.42e-06	5.93e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TGFB1—periodontitis	8.42e-06	5.93e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	8.41e-06	5.93e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—TGFB1—periodontitis	8.36e-06	5.89e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—TGFB1—periodontitis	8.33e-06	5.87e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP9—periodontitis	8.3e-06	5.85e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CXCL8—periodontitis	8.27e-06	5.83e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP9—periodontitis	8.22e-06	5.79e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—FGF2—periodontitis	8.06e-06	5.68e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GGT1—periodontitis	8.05e-06	5.67e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL6—periodontitis	7.97e-06	5.62e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTGS2—periodontitis	7.97e-06	5.62e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGS2—periodontitis	7.97e-06	5.62e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TGFB1—periodontitis	7.95e-06	5.6e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCL2—periodontitis	7.95e-06	5.6e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GGT1—periodontitis	7.86e-06	5.54e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CXCL8—periodontitis	7.85e-06	5.53e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CXCL8—periodontitis	7.83e-06	5.52e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	7.67e-06	5.4e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PPARA—periodontitis	7.62e-06	5.37e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP9—periodontitis	7.62e-06	5.37e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—TGFB1—periodontitis	7.51e-06	5.29e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP9—periodontitis	7.48e-06	5.27e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GGT1—periodontitis	7.34e-06	5.17e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL6—periodontitis	7.32e-06	5.16e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—periodontitis	7.29e-06	5.14e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—FGF2—periodontitis	7.19e-06	5.06e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—periodontitis	7.19e-06	5.06e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP9—periodontitis	7.1e-06	5e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP9—periodontitis	7.08e-06	4.99e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL8—periodontitis	7.05e-06	4.97e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TGFB1—periodontitis	6.84e-06	4.82e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—periodontitis	6.82e-06	4.81e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—periodontitis	6.8e-06	4.79e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFB1—periodontitis	6.77e-06	4.77e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—periodontitis	6.76e-06	4.77e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—periodontitis	6.76e-06	4.76e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFB1—periodontitis	6.69e-06	4.72e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—periodontitis	6.63e-06	4.68e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPARA—periodontitis	6.45e-06	4.55e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—periodontitis	6.38e-06	4.5e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—periodontitis	6.34e-06	4.47e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—periodontitis	6.3e-06	4.44e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL8—periodontitis	6.29e-06	4.43e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—periodontitis	6.28e-06	4.43e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFB1—periodontitis	6.28e-06	4.42e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFB1—periodontitis	6.17e-06	4.34e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—periodontitis	6.13e-06	4.32e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—periodontitis	5.99e-06	4.22e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—periodontitis	5.98e-06	4.21e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—periodontitis	5.97e-06	4.21e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFB1—periodontitis	5.85e-06	4.12e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFB1—periodontitis	5.84e-06	4.11e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARA—periodontitis	5.76e-06	4.06e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—periodontitis	5.69e-06	4.01e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—periodontitis	5.66e-06	3.99e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARA—periodontitis	5.62e-06	3.96e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—periodontitis	5.46e-06	3.85e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFB1—periodontitis	5.26e-06	3.71e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARA—periodontitis	5.25e-06	3.7e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—periodontitis	5.15e-06	3.63e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—periodontitis	5.1e-06	3.6e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—periodontitis	5.04e-06	3.55e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—periodontitis	4.96e-06	3.49e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GGT1—periodontitis	4.84e-06	3.41e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—periodontitis	4.73e-06	3.33e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFB1—periodontitis	4.69e-06	3.3e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—periodontitis	4.65e-06	3.27e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—periodontitis	4.41e-06	3.11e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—periodontitis	4.4e-06	3.1e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—periodontitis	4.2e-06	2.96e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—periodontitis	3.96e-06	2.79e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—periodontitis	3.75e-06	2.64e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—periodontitis	3.66e-06	2.58e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—periodontitis	3.53e-06	2.49e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARA—periodontitis	3.46e-06	2.44e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—periodontitis	3.42e-06	2.41e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—periodontitis	2.25e-06	1.59e-05	CbGpPWpGaD
